Your browser doesn't support javascript.
loading
A case report of disappearing pigmented skin lesions associated with pembrolizumab treatment for metastatic melanoma.
Wolner, Z J; Marghoob, A A; Pulitzer, M P; Postow, M A; Marchetti, M A.
Affiliation
  • Wolner ZJ; Department of Medicine, Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY, U.S.A.
  • Marghoob AA; Department of Medicine, Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY, U.S.A.
  • Pulitzer MP; Department of Pathology, Dermatopathology Service, Memorial Sloan Kettering Cancer Center, New York, NY, U.S.A.
  • Postow MA; Department of Medicine, Melanoma and Immunotherapeutics Service, Memorial Sloan Kettering Cancer Center, New York, NY, U.S.A.
  • Marchetti MA; Weill Cornell Medical College, New York, NY, U.S.A.
Br J Dermatol ; 178(1): 265-269, 2018 01.
Article in En | MEDLINE | ID: mdl-28132411

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pigmentation Disorders / Skin Neoplasms / Antibodies, Monoclonal, Humanized / Antineoplastic Agents, Immunological / Liver Neoplasms / Melanoma Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans / Male / Middle aged Language: En Journal: Br J Dermatol Year: 2018 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pigmentation Disorders / Skin Neoplasms / Antibodies, Monoclonal, Humanized / Antineoplastic Agents, Immunological / Liver Neoplasms / Melanoma Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans / Male / Middle aged Language: En Journal: Br J Dermatol Year: 2018 Type: Article Affiliation country: United States